Structure-based development of specific inhibitors for individual cathepsins and their medical applications

Proceedings of the Japan Academy Series B: Physical and Biological Sciences

Volumn 87, Issue 2, 2011, Pages 29-39

  Katunuma, Nobuhiko ^a  

^a TOKUSHIMA BUNRI UNIVERSITY   (Japan)

Author keywords

Autoimmune diseases; Cathepsin; Cystatin; Inhibitor; Osteoporosis; Sj gren syndrome

Indexed keywords

CATHEPSIN; PROTEINASE INHIBITOR;

ANIMAL; CHEMISTRY; DRUG ANTAGONISM; GENERAL ASPECTS OF DISEASE; HUMAN; REVIEW; STRUCTURE ACTIVITY RELATION;

ANIMALS; CATHEPSINS; DISEASE; HUMANS; PROTEASE INHIBITORS; STRUCTURE-ACTIVITY RELATIONSHIP;

ANIMALIA; MUS;

EID: 79951613664     PISSN: 03862208     EISSN: 13492896     Source Type: Journal    
DOI: 10.2183/pjab.87.29     Document Type: Review

References (26)

1. Turk, V., Turk, B. and Turk, D. (2001) Lysosomal cysteine proteases facts and opportunities. EMBO J. 20, 4629-4633.
2. Hanada, K., Tamai, M., Yamagishi, M., Ohmura, S., Sawada, J. and Tanaka, I. (1978) Isolation and characterization of E-64, a new thiol protease Inhibitor. Agric. Biol. Chem. Tokyo 42, 523-528.
3. Hashida, S., Towatari, T., Kominami, E. and Katunuma, N. (1980) Inhibition by E-64 derivatives of rat liver cathepsin B and cathepsin L in vitro and in vivo. J. Biochem. 88, 1805-1811.
4. Hara, K., Kominami, E., Ii, K. and Katunuma, N. (1988) Effect of proteinase inhibitors on intracellular processing of cathepsin B, H and L in rat macrophages. FEBS Lett. 231, 229-231.
5. Hori, M., Hemmi, H., Suzukake, K., Hayashi, H., Uehara, Y., Takeuti, T. and Umezawa, H. (1978) Biosynthesis of leupeptin. J. Antibiot. (Tokyo) 31, 95-98.
6. Umezawa, H., Aoyagi, T., Morishita, T., Kunimoto, S., Matsuzaki, M., Hamada, M. and Takeuchi, T. (1970) Chymostatin, a new chymotrypsin inhibitor produced by actinomycetes. J. Antibiot. (Tokyo) 23, 425-427.
7. Katunuma, N., Murata, E., Kakegawa, H., Matsui, A., Tsuzuki, H., Tsuge, H., Turk, D., Turk, V., Fukushima, M., Tada, Y. and Asao, T. (1999) Structure based development of novel specific inhibitors for cathepsin L and cathepsin S in vitro and in vivo. FEBS Lett. 458, 6-10.
8. Tsuge, H., Nishimura, T., Tada, Y., Asao, T., Turk, D., Turk, V. and Katunuma, N. (1996) Inhibition mechanism of cathepsin L-specific inhibitors based on the crystal structure of papain-CLIK148 complex. Biochem. Biophys. Res. Commun. 266, 411-416.
9. Katunuma, N., Matsui, A., Inubushi, T., Murata, E., Kakegawa, H., Ohba, Y., Turk, D., Turk, V., Tada, Y. and Asao, T. (2000) Structure-based development of pyridoxal propionate derivatives as specific inhibitors of cathepsin K in vitro and in vivo. Biochem. Biophys. Res. Commun. 267, 850-854.
10. Katunuma, N., Tsuge, H., Nukatsuka, M, Asao, T. and Fukushima, M. (2002) Structure-based design of specific cathepsin inhibitors and their application to protection of bone metastases of cancer cells. Arch. Biochem. Biophys. 397 (2), 305-311.
11. Turk, D., Podobnik, M., Popovic, T., Katunuma, N., Bode, W., Huber, R. and Turk, V. (1995) Crystal structure of cathepsin B inhibited with CA030 at 2.0-Å resolution: A basis for the design of specific epoxysuccinyl inhibitors. Biochemistry 34, 4791-4797.
12. Murata, M., Miyashita, S., Yokoo, C., Tamai, M., Hanada, K. and Katunuma, N. (1991) Novel epoxysuccinyl peptides. Selective inhibitors of cathepsin B, in vitro. FEBS Lett. 280, 307-310.
13. Katunuma, N. and Kominami, E. (1995) Structure, properties, mechanisms, and assays of cysteine protease inhibitors: cystatins and E-64 derivatives. Methods Enzymol. 251, 382-397.
14. Musil, D., Zucic, D., Turk, D., Engh, R.A., Mayr, I., Huber, R., Popovic, T., Turk, V., Towatari, T., Katunuma, N. and Bode, W. (1991) The refined 2.15Å X-ray crystal structure of human liver cathepsin B: the structural basis for its specificity. EMBO J. 10, 2321-2330.
15. 6. Biochem. Biophys. Res. Commun. 271, 151-155.
16. + T cell differentiation from Th2 to Th1 by treatment with cathepsin B inhibitor in experimental leishmaniasis. J. Immunol. 161, 2120-2127.
17. Katunuma, N. (1997) New aspects on antigen presentation mechanism for immune-responses and allergy expression. Medical Aspects of Proteases and Protease Inhibitors. IOS Press, Amsterdam, pp. 153-172.
18. Kitamura, H., Kamon, H., Sawa, S., Park, S.J., Katunuma, N., Ishihara, K., Murakami, M. and Hirano, T. (2005) IL-6-STAT3 controls intracellular MHC class II,αβ dimer level through cathepsin S activity in dendritic cells. Immunity 23, 491-502.
19. Zhang, T., Maekawa, Y., Yasutomo, K., Ishikawa, H., Fawzy Nashed, B., Dainichi, T., Hisaeda, H., Sakai, T., Kasai, M., Mizuochi, T., Asao, T., Katunuma, N. and Himeno, K. (2000) Pepstatin-A sensitive aspartic proteases in lysosome are involved in degradation of the invariant chain and antigen-processing in antigen presenting cells of mice infected with Leishmania major. Biochem. Biophys. Res. Commun. 276, 693-701.
20. Saegusa, K., Ishimura, N., Yanagi, K., Arakaki, R., Ogawa, K., Saito, I., Katunuma, N. and Hayashi, Y. (2002) Cathepsin S inhibitor prevents autoantigen presentation and autoimmunity. J. Clin. Invest. 110 (3), 361-369.
21. Ishimaru, N., Arakaki, R., Katunuma, N. and Hayashi, Y. (2004) Critical role of cathepsin inhibitors for autoantigen processing and autoimmunity. Adv. Enzyme Regul. 44, 309-320.
22. Katunuma, N. (1997) Molecular mechanisms of bone collagen degradation in bone resorption. J. Bone Miner. Metab. 15, 1-8.
23. Yang, M., Zhang, Y., Pan, J., Sun, J., Liu, J., Libby, P., Sukhova, G.K., Doria, A., Katunuma, N., Peroni, O.D., Guerre-Millo, M., Kahn, B.B., Clement, K. and Shi, G.P. (2007) Cathepsin L activity controls adipogenesis and glucose tolerance. Nat. Cell Biol. 9, 970-977.
24. Delaissé, J.M., Eeckhout, Y. and Vaes, G. (1984) In vivo and in vitro evidence for the involvement of cysteine proteinases in bone resorption. Biochem. Biophys. Res. Commun. 125 (2), 441-447.
25. Kirschke, H., Kembhavi, A.A., Bohley, P. and Barrett, A.J. (1982) Action of rat liver cathepsin L on collagen and other substrates. Biochem. J. 201 (2), 367-372.
26. Katunuma, N. (1992) Intracellular Protein Degradation Mechanisms. Tokyo Kagaku Dojin, Tokyo.